Spots Global Cancer Trial Database for sacituzumab
Every month we try and update this database with for sacituzumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer | NCT06040970 | Ovarian Cancer Malignant Neopl... | Sacituzumab Cisplatin | 18 Years - | Icahn School of Medicine at Mount Sinai | |
A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies | NCT04927884 | Advanced Triple... | N-803 PD-L1 t-haNK Sacituzumab Gov... Cyclophosphamid... | 18 Years - | ImmunityBio, Inc. | |
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer | NCT06040970 | Ovarian Cancer Malignant Neopl... | Sacituzumab Cisplatin | 18 Years - | Icahn School of Medicine at Mount Sinai | |
A Study of Sacituzumab With Chemoimmunotherapy to Treat Advanced Triple-Negative Breast Cancer After Prior Therapies | NCT04927884 | Advanced Triple... | N-803 PD-L1 t-haNK Sacituzumab Gov... Cyclophosphamid... | 18 Years - | ImmunityBio, Inc. |